Endocrine system basics

General endocrinology

Endocrinology is the study of the endocrine system (i.e., the hypothalamus, pituitary gland, thyroid gland, adrenals, and gonads), metabolic diseases, and certain aspects of nutritional medicine. The endocrine glands are responsible for producing and secreting hormones, which influence the function of cells in certain tissues of the body. Hormone secretion is controlled by highly regulated pathways, the most important of which is the hypothalamic-pituitary axis . The hypothalamus secretes and stores nontropic hormones (e.g., ADH, oxytocin) and releasing hormones (e.g., TRH, CRH, GnRH). The pituitary gland is composed of the anterior pituitary, which secretes tropic hormones (e.g., ACTH, TSH, FSH, LH) and whose function is controlled by hypothalamic releasing hormones, and the posterior pituitary , which stores ADH and oxytocin. The gonads are the ovaries in female individuals and testicles in male individuals. Their function is controlled via the hypothalamic-pituitary-gonadal axis , as well as the secretion of sex hormone-binding globulin (SHBG). Disruption of the hypothalamic-pituitary axis can result in the development of various endocrine disorders, which are classified according to the level of pathway disruption: primary (disorders of the peripheral endocrine gland), secondary (pituitary dysfunctions), and tertiary (hypothalamic disorders). An understanding of these hormone pathways is important for the diagnosis and management of endocrine disorders, particularly when interpreting changes in hormone levels and the results of suppression and/or stimulation tests.

Overview of endocrinological diseases

This article focuses on the hypothalamic-pituitary axis. Other important structures, hormones, and metabolic diseases are discussed in their respective articles.

  • Types of endocrinological diseases
    • Primary disease: caused by disorders of the endocrine gland (e.g., Addison disease)
    • Secondary disease: caused by disorders of the pituitary (e.g., Cushing disease)
    • Tertiary disease: caused by disorders of the hypothalamus (e.g., hypothalamic trauma, hemorrhage)
    • Diabetes mellitus
    • Metabolic syndrome
    • Osteoporosis (See “ Calcium homeostasis ” in “ Hypocalcemia ”)
    • Pituitary gland
      • Hypopituitarism
      • Prolactinoma
      • Acromegaly
      • Diabetes insipidus
      • SIADH
      • Central precocious puberty
      • Hypocortisolism
      • Cushing syndrome
      • Primary hyperaldosteronism
      • Congenital adrenal hyperplasia
      • Adrenal insufficiency
      • Hypothyroidism
      • Hyperthyroidism
      • Hypogonadotropic hypogonadism
      • Hypergonadotropic hypogonadism

      Basics of endocrinology

      Hormones

      • Definition
        • Hormones are endogenous messengers produced by endocrine glands or single cells that are responsible for signal transduction .
        • They influence the function and metabolic rate of other organs and cells in the body.
        • Complex regulatory circuits (e.g., the hypothalamic-pituitary axis ) control their secretion.
        • Affect the neighboring cells via diffusion
        • D cells of the stomach produce somatostatin to inhibit neighboring G cells from secreting gastrin.
        • Affect the secreting cell itself
        • Autocrine signaling is particularly important for the self-renewal of embryonic stem cells. [1]
        • Secreted into the bloodstream to reach their targets
        • Pancreaticβ cells secrete insulin directly into the bloodstream to stimulate the uptake of glucose by the hepatic, muscle, and adipose tissue cells.
        • Derived from cholesterol
        • Testosterone
        • Progesterone
        • Estrogen
        • Glucocorticoids
        • Mineralocorticoids
        • Derived from a single amino acid such as phenylalanine, tyrosine, or tryptophan
        • Catecholamines
        • Thyroid hormones ( T3 and T4 )
        • Derived from a few or many amino acids
        • Oxytocin
        • Vasopressin
        • Prolactin
        • Glucagon
        • Insulin
        • Diffuse through the lipid plasma membrane of cells, bind to intracellular receptors, and affect transcription
        • Usually have long-term effects with delayed onset (e.g., sex hormones)
        • Steroid hormones
        • Thyroid hormones
        • Water-soluble
        • Bind to receptorproteins on the cellular membrane
        • Amine and peptide hormones (except for thyroid hormones, which are lipophilic)

        Hydrophilic hormones (e.g., catecholamines) are stored in secretory granules and released when needed. Lipophilic hormones (e.g., adrenocortical steroid hormones) pass into the bloodstream once synthesized without being stored in cells.

        • Degradation of hormones
          • Steroid hormones and thyroid hormones: inactivation and conjugation in the liver and excretion in bile
          • Catecholamines: enzymatic degradation and excretion in urine (e.g., vanillylmandelic acid )
          • Peptide/protein hormones: proteolytic degradation mainly in the liver and kidneys

          Feedback control mechanisms

          Hormone secretion is controlled by the following feedback mechanisms: [2]

          • Negative feedback
            • Hormone secretion by the endocrine gland suppresses the release of hypothalamic and pituitaryhormones.
            • Negative feedback loop types include:
              • Ultrashort feedback loop: Hypothalamichormones inhibit their own secretion via autocrine effects.
              • Short feedback loop: Pituitaryhormones inhibit the release of hypothalamichormones.
              • Long feedback loop: Hormones from peripheral endocrine glands inhibit the release of hypothalamic and pituitaryhormones.
              • Hormone secretion enhances its own production.
              • Example: Uterine stretching during labor contractions under the influence of oxytocin triggers the release of more oxytocin from the posterior pituitary.

              Diagnosis of endocrine diseases

              • Direct measurement of hormone blood levels (e.g., measuring prolactin blood level upon suspicion of prolactinoma )
              • Stimulation of glands to detect underactivity (e.g., ACTH stimulation test for Addison disease )
              • Inhibition of glands to detect hyperactivity (e.g., dexamethasone suppression test for Cushing syndrome )
              • Imaging of glands to determine:
                • Morphological abnormalities (e.g., thyroid ultrasound)
                • Functional abnormalities (e.g., thyroid scintigraphy)

                Hypothalamus and pituitary gland

                Hypothalamus

                • Anatomy
                  • Ventral part of the diencephalon (see “ Diencephalon ”)
                  • Composed of multiple nuclei (e.g., lateral nucleus, preoptic nucleus)
                  • Regulation of hormonal secretion by the anterior pituitary gland via the hypothalamic-pituitary axis
                  • Secretion/storage of ADH and oxytocin
                    • ADH and oxytocin are produced in the supraoptic nucleus and paraventricular nucleus of the hypothalamus .
                    • Both hormones are transported to the posterior pituitary via neurophysins (a group of carrier proteins ) and released into the circulation as needed.
                    • Inhibiting hormones
                      • Function: decrease hormonal secretion from the pituitary gland
                      • Examples: somatostatin, dopamine
                      • Function: increase hormonal secretion from the pituitary gland
                      • Examples: thyrotropin-releasing hormone (TRH), corticotropin-releasing hormone (CRH), gonadotropin-releasing hormone (GnRH), growth hormone-releasing hormone (GHRH)

                      Pituitary gland (hypophysis)

                      • Anatomy
                        • Located in the sella turcica (midline depression of the sphenoid bone) of the middle cranial fossa
                        • Connected to the hypothalamus via the pituitary stalk (a tube-like structure between the median eminence of the hypothalamus and the posterior pituitary that contains the axons of the posterior pituitaryneurons)
                        • Consists of two major parts:
                          • Anterior pituitary gland ( adenohypophysis ): develops from oral ectoderm ( Rathke pouch)
                          • Posterior pituitary gland ( neurohypophysis ): develops from neural ectoderm
                          • Acidophil cells
                            • Secrete prolactin and growth hormone (GH)
                            • Stain well with acidic dyes such as eosin
                            • Secrete adrenocorticotropic hormone (ACTH), thyroid-stimulating hormone (TSH), luteinizing hormone (LH), and follicle-stimulating hormone (FSH)
                            • Stain well with basic dyes (e.g., hematoxylin)
                            • Do not secrete hormones [3]
                            • Stain poorly with both acidic and basic dyes
                            • Anterior pituitary gland
                              • Regulation of endocrine gland function via the release of tropic hormones
                              • Secretion of nontropic hormones with direct peripheral effects
                              • Tropic hormones : act on endocrine glands to mediate their effects
                                • All pituitary glycoprotein hormones (e.g., FSH, LH, TSH) have a common alpha subunit .
                                • Each hormone has a unique beta subunit .

                                “ B-FLAT ”: B asophils secrete F SH, L H, A CTH, and T SH.

                                “ P i G on Acid”: P rolactin and G H are secreted by Acid ophils.

                                Hypothalamus and anterior pituitary

                                Tropic hormones

                                • CRH
                                  • Stimulates ACTH, MSH, and β-endorphin secretion from proopiomelanocortin (POMC) precursor
                                  • CRH levels decrease after long-term steroid treatment via negative feedback.
                                  • ACTH
                                    • Stimulates adrenalglucocorticoid and androgen production
                                    • Cleaved in the corticotropic cells of the anterior pituitary
                                    • ACTH and MSH share the common precursor POMC , which explains the hyperpigmentation seen in Cushing disease.
                                    • Adrenal cortex
                                    • TRH
                                      • Stimulates TSH and prolactin secretion
                                      • An increase in TRH levels (e.g., in primary/secondary hypothyroidism) may result in the development of galactorrhea because it stimulates prolactin secretion.
                                      • TSH
                                        • Stimulates thyroid hormone production
                                        • TSH secretion is inhibited by dopamine, somatostatin, and glucocorticoids. [4]
                                        • TSH levels are the best initial test in the workup of hypothyroidism.
                                        • Thyroid gland
                                        • GnRH
                                          • Stimulates FSH and LH secretion
                                          • During breastfeeding, high prolactin levels cause supressed GnRH secretion, which results in the development of lactational amenorrhea.
                                          • Pulsatile GnRH secretion is responsible for puberty and reproductive function.
                                          • Gonadotropins
                                            • LH
                                              • Female individuals: triggers ovulation
                                              • Male individuals: stimulates testosterone synthesis in Leydig cells
                                              • Gonads
                                                • Female individuals: ovaries
                                                • Male individuals: testicles

                                                Nontropic hormones

                                                • GHRH
                                                  • Stimulates GH secretion
                                                  • Synthetic forms of GHRH (tesamorelin) can be used for abdominal fat reduction in HIV-associated lipodystrophy.
                                                  • GH (growth hormone, somatotropin)
                                                    • Direct effects
                                                      • ↓ Glucose uptake into cells ( ↑ insulin resistance )
                                                      • ↑ Lipolysis
                                                      • ↑ Protein synthesis in muscle
                                                      • ↑ Amino acid uptake
                                                      • Growth stimulation
                                                      • Anabolic effect on body
                                                      • ↑ GH secretion: exercise, deep sleep, puberty, hypoglycemia, CKD , thyroid hormone, estrogen, testosterone, and short-term glucocorticoid exposure
                                                      • ↓ GH secretion: glucose, somatostatin, somatomedin , free fatty acids, and chronic glucocorticoid therapy [6] [7]
                                                      • Somatostatin
                                                        • Inhibits GH and TSH secretion
                                                        • Synthetic forms of somatostatin are used in the treatment of acromegaly (e.g., octreotide).
                                                        • Dopamine ( prolactin-inhibiting hormone ): inhibits secretion of prolactin in the pituitary gland
                                                        • Prolactin (secreted by lactotropic cells )
                                                          • ↑ Breast tissue growth and lactation
                                                          • Inhibits GnRH secretion
                                                            • Female individuals
                                                              • Inhibition of ovulation
                                                              • Amenorrhea
                                                              • Galactorrhea
                                                              • Decreased libido
                                                              • Inhibition of spermatogenesis
                                                              • Decreased libido
                                                              • TRH: stimulates the secretion of prolactin (but is not part of the hypothalamic-pituitary-prolactin axis )
                                                              • Melanocyte-inhibiting hormone : inhibits release of MSH
                                                              • α-MSH
                                                                • Cleaved in the arcuate nucleus
                                                                • Regulation of appetite and metabolism: promotes satiety [8]
                                                                • Stimulates melanogenesis → melanocyte stimulation → hyperpigmentation

                                                                “No PRO-B L AM :” Derivatives of PRO opiomelanocortin are B eta- endorphin , A CTH, and M SH.

                                                                Hypothalamus and posterior pituitary

                                                                • Plasma osmolality: sensed by hypothalamic osmoreceptors
                                                                • Hypovolemia: sensed by the atrial stretch receptors
                                                                • Hypotension: sensed by the peripheral baroreceptors
                                                                • Angiotensin II : sensed by hypothalamicreceptors
                                                                • Regulation of plasma osmolality
                                                                  • Mediated by V2 receptors
                                                                  • Insertion of aquaporin channels in the principal cells of the renal collecting duct and DCT [10]
                                                                  • Results in increased water reabsorption
                                                                  • Mediated by V1 receptors
                                                                  • Vasoconstrictive effects at higher levels
                                                                  • Elevated in SIADH despite plasma hypoosmolality
                                                                  • ADH deficiency or resistance can lead to diabetes insipidus.
                                                                  • Alcohol inhibits ADH release and causes diuresis. [12]
                                                                  • Nipple stimulation
                                                                  • Stretching of the vagina or cervix
                                                                  • Promotes uterine contractions during labor
                                                                  • Facilitates milk ejection reflex via myoepithelial cell contraction
                                                                  • Involved in the neuromodulation of social and reproductive behavior, fear, anxiety, and depression
                                                                  • Goserelin
                                                                  • Leuprolide
                                                                  • Nafarelin
                                                                  • Histrelin
                                                                  • Excessive pituitary stimulation → ↓ GnRHreceptors → ↓ LH and FSH secretion → ↓ estradiol production in ovaries, ↓ testosterone in male individuals [13]
                                                                  • Transient agonist effects are followed by the suppression of the hypothalamic-pituitary-gonadal axis .
                                                                  • Cancer (continuous administration)
                                                                    • Breast cancer
                                                                    • Prostate cancer
                                                                    • Hypogonadism
                                                                      • Decreased libido
                                                                      • Vaginal dryness
                                                                      • Hot flashes
                                                                      • Degarelix
                                                                      • Block GnRHreceptors on pituitary to decrease FSH and LH secretion
                                                                      • Prostate cancer
                                                                      • In vitro fertilization [14]
                                                                      • Hypogonadism
                                                                      • Hot flashes
                                                                      • Elevated liver enzymes
                                                                      • Nausea, vomiting
                                                                      • Octreotide
                                                                      • Lanreotide
                                                                      • Inhibit GH secretion
                                                                      • Inhibit the release of splanchnicvasodilatoryhormones (e.g., gastrin, glucagon, insulin, VIP)
                                                                      • Acromegaly
                                                                      • Carcinoid tumor
                                                                      • VIPoma
                                                                      • Acute esophageal variceal bleeding
                                                                      • Glucagonoma
                                                                      • Gastrinoma
                                                                      • Insulinoma
                                                                      • General
                                                                        • Fatigue, weakness
                                                                        • Depressed mood
                                                                        • Steatorrhea
                                                                        • Nausea , vomiting
                                                                        • Abdominal pain, cramps
                                                                        • Cholelithiasis (due to inhibition of cholecystokinin)
                                                                        • Tesamorelin
                                                                        • Stimulate GHreceptors
                                                                        • Growth hormone deficiency
                                                                        • Turner syndrome
                                                                        • HIV-associated lipodystrophy
                                                                        • Short stature (e.g., in children with CKD) [16]
                                                                        • Idiopathic intracranial hypertension
                                                                        • Increased insulin resistance
                                                                        • Prepubertal gynecomastia
                                                                        • Slipped capital femoral epiphysis
                                                                        • Progression of scoliosis
                                                                        • Pegvisomant
                                                                        • Block GHreceptor
                                                                        • Acromegaly
                                                                        • Hepatotoxicity
                                                                        • Bromocriptine
                                                                        • Cabergoline
                                                                        • Stimulate dopaminereceptors
                                                                        • Prolactinoma
                                                                        • Parkinson disease
                                                                        • Neuroleptic malignant syndrome
                                                                        • Malignant hyperthermia
                                                                        • Nausea, vomiting
                                                                        • Orthostatic hypotension
                                                                        • Confusion, hallucination
                                                                        • Dyskinesia
                                                                        • Conivaptan
                                                                        • Tolvaptan
                                                                        • Demeclocycline (a tetracycline)
                                                                        • Block V2 receptors and decrease water reabsorption in the renal collecting duct
                                                                        • Tolvaptan: selective V2 receptorantagonism
                                                                        • Conivaptan: dual V1A and V2 receptorantagonism
                                                                        • Demeclocycline seems to disrupt the intracellular second messenger cascade that follows after the binding of vasopressin to the V2 receptor in renal collecting ducts → ↓ ADH effect
                                                                        • Euvolemic hyponatremia (e.g., SIADH )
                                                                        • Hypervolemic hyponatremia (e.g., congestive heart failure, liver cirrhosis )
                                                                        • Demeclocycline: bacterial infections
                                                                        • Hypernatremia
                                                                        • Nephrogenic DI (specific to demeclocycline)
                                                                        • Hypotension
                                                                        • Dry mouth
                                                                        • Liver failure [19]
                                                                        • Nausea, vomiting, stomachpain
                                                                        • Increased thirst, hunger, urination
                                                                        • Weight loss
                                                                        • CYP3A (including CYP3A4) inhibition and CYP3A induction
                                                                        • Demeclocycline
                                                                          • Azotemia and nephrotoxicity
                                                                          • Hepatotoxicity
                                                                          • Skin reactions
                                                                          • Desmopressin
                                                                          • Terlipressin
                                                                          • Act on the V1 and V2 receptors
                                                                          • Release vWF stored in the endothelium
                                                                          • Central DI
                                                                          • Von Willebrand disease
                                                                          • Hemophilia A
                                                                          • Nocturnal enuresis
                                                                          • Hyponatremia
                                                                          • Oxytocin
                                                                          • Mediates calcium influx → uterine contraction
                                                                          • Induction of labor
                                                                          • Augmentation of labor
                                                                          • Postpartum hemorrhage
                                                                          • Hyponatremia
                                                                          • Tachysystole
                                                                          • Hypotension

                                                                          Adrenal cortex

                                                                          • The adrenal cortex consists of three distinct layers:
                                                                            • Zona glomerulosa: produces mineralocorticoids (i.e., aldosterone )
                                                                            • Zona fasciculata: produces glucocorticoids (i.e., cortisol )
                                                                            • Zona reticularis: produces androgens (i.e., dehydroepiandrosterone )
                                                                            • ↑ Hypothalamic secretion of CRH → ↑ ACTH secretion from the pituitary → ↑ synthesis of glucocorticoids and androgens from the adrenal cortex
                                                                            • Mineralocorticoids are secreted as a result of renin-angiotensin-aldosterone system activation.

                                                                            Thyroid gland

                                                                            • The thyroid gland cells produce the following hormones: [20]
                                                                              • Follicular cells: the thyroid hormones T3 (triiodothyronine) and T4 (tetraiodothyronine)
                                                                              • Parafollicular cells: calcitonin
                                                                              • ↑ Hypothalamic secretion of TRH → ↑ TSH secretion from the pituitary → ↑ thyroid hormone production
                                                                              • Calcitonin is not controlled by the hypothalamic-pituitary-thyroid axis . It is released in response to increased serum Ca 2+ levels .

                                                                              Gonads

                                                                              Overview

                                                                              • Definition
                                                                                • Gonads are reproductive organs that produce gametes and sex hormones.
                                                                                • The male gonad is the testicle and the female gonad is the ovary.
                                                                                • Male individuals: testosterone, dihydrotestosterone
                                                                                • Female individuals: estrogen, progesterone
                                                                                • LH
                                                                                • FSH
                                                                                • GnRH

                                                                                Physiological effects of LH and FSH

                                                                                Physiological effects of sex hormones

                                                                                Feedback control mechanisms

                                                                                • Hypothalamus
                                                                                  • Central regulation
                                                                                    • Pulsatile release of GnRH during puberty stimulates secretion of FSH, LH, and sex hormones.
                                                                                    • GnRH secretion may be influenced by competitive sports, malnutrition, or stress, any of which can lead to amenorrhea in women.
                                                                                    • Androgen
                                                                                    • Estrogen
                                                                                    • Progesterone
                                                                                    • Inhibin
                                                                                    • Hyperestrogenism (e.g., pregnancy, OCP use) causes increased SHBG levels.
                                                                                    • Female individuals with low levels of SHBG (e.g., PCOS) have higher levels of free testosterone, which is responsible for the development of hirsutism in these patients.
                                                                                    • Male individuals with high estrogen levels (e.g., in liver cirrhosis) are at risk of developing gynecomastia because of increased SHBG levels and decreased free testosterone levels.

                                                                                    Regulation of appetite and satiety

                                                                                    Overview [22] [23] [24]

                                                                                    • Input
                                                                                      • Gastrointestinal system
                                                                                        • Endocrine hormones: released into the circulation in response to feeding/fasting state
                                                                                        • Vagal afferents: relay signals from intestinal mechanoreceptors to the nucleus tractus solitarius
                                                                                        • Orexigenic neurons
                                                                                          • Stimulate appetite
                                                                                          • Release neuropeptide Y and agouti-related peptide
                                                                                          • Suppress appetite
                                                                                          • Release POMC
                                                                                          • Lateral nucleus of the hypothalamus (hunger center): appetite stimulation
                                                                                          • Ventromedial nucleus of the hypothalamus (satiety center): appetite suppression
                                                                                          • Polyphagia : excessive hunger (e.g., in hyperthyroidism, Prader-Willi syndrome )
                                                                                          • Anorexia: a loss of appetite (e.g., in cancer, HIV)

                                                                                          Regulation of appetite

                                                                                          Regulation of satiety [22] [24]

                                                                                          Ghrelin makes you G ain weight. Leptin makes you L ose weight.

                                                                                          Appetite regulators

                                                                                          References

                                                                                          1. Robertson JF, Blamey RW. . The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women. . European Journal of Cancer. 2003 .
                                                                                          2. Tarlatzis BC . GnRH antagonists in ovarian stimulation for IVF . Hum Reprod Update. 2006 ; 12 (4) : p.333-340 . doi: 10.1093/humupd/dml001 . | Open in Read by QxMD
                                                                                          3. Souza FM, Collett-Solberg PF . Adverse effects of growth hormone replacement therapy in children . Arquivos Brasileiros de Endocrinologia & Metabologia. 2011 ; 55 (8) : p.559-565 . doi: 10.1590/s0004-27302011000800009 . | Open in Read by QxMD
                                                                                          4. Gupta V, Lee M . Lee M. Growth hormone in chronic renal disease . Indian J Endocrinol Metab. 2012 ; 16 (2) : p.195-203 . doi: 10.4103/2230-8210.93736 . | Open in Read by QxMD
                                                                                          5. Narayen G, Mandal S . Vasopressin receptor antagonists and their role in clinical medicine . Indian Journal of Endocrinology and Metabolism. 2012 ; 16 (2) : p.183-191 . doi: 10.4103/2230-8210.93734 . | Open in Read by QxMD
                                                                                          6. Katzung BG . Basic and Clinical Pharmacology 14th Edition. McGraw Hill Professional ; 2017
                                                                                          7. $ SAMSCA® (tolvaptan) tablets, for oral use .
                                                                                          8. Przybyla L, Voldman J . Probing Embryonic Stem Cell Autocrine and Paracrine Signaling Using Microfluidics . Annual Review of Analytical Chemistry. 2012 ; 5 : p.293-315 . doi: 10.1146/annurev-anchem-062011-143122 . | Open in Read by QxMD
                                                                                          9. Prummel MF, Brokken LJS, Wiersinga WM . Ultra Short-Loop Feedback Control of Thyrotropin Secretion . Thyroid. 2004 ; 14 (10) : p.825-829 . doi: 10.1089/thy.2004.14.825 . | Open in Read by QxMD
                                                                                          10. Standring S . Gray’s Anatomy: The Anatomical Basis of Clinical Practice. Elsevier Health Sciences ; 2016
                                                                                          11. Nussey S, Whitehead S . Endocrinology: An Integrated Approach. BIOS Scientific Publishers ; 2011
                                                                                          12. Alhalabi M . Predictive value of serum Inhibin-B levels as an indicator of the presence of testicular spermatozoa in non-obstructive azoospermia . Middle East Fertility Society Journal. 2016 ; 21 (4) : p.246-252 . doi: 10.1016/j.mefs.2016.05.001 . | Open in Read by QxMD
                                                                                          13. Haugen BR . Drugs that suppress TSH or cause central hypothyroidism . Best Practice & Research Clinical Endocrinology & Metabolism. 2009 ; 23 (6) : p.793-800 . doi: 10.1016/j.beem.2009.08.003 . | Open in Read by QxMD
                                                                                          14. Murray PG, Clayton PE . Endocrine Control of Growth . American Journal of Medical Genetics Part C: Seminars in Medical Genetics. 2013 ; 9999 : p.1-10 . doi: 10.1002/ajmg.c.31357 . | Open in Read by QxMD
                                                                                          15. Mazziotti G, Giustina A . Glucocorticoids and the regulation of growth hormone secretion . Nature Reviews Endocrinology. 2013 ; 9 (5) : p.265-276 . doi: 10.1038/nrendo.2013.5 . | Open in Read by QxMD
                                                                                          16. Cordido F, Peino R, et al . Impaired growth hormone secretion in obese subjects is partially reversed by acipimox-mediated plasma free fatty acid depression. . The Journal of Clinical Endocrinology & Metabolism. 1996 ; 81 (3) : p.914-918 . doi: 10.1210/jcem.81.3.8772550 . | Open in Read by QxMD
                                                                                          17. Kim JD, Leyva S, Diano S . Hormonal regulation of the hypothalamic melanocortin system . Frontiers in Physiology. 2014 ; 5 . doi: 10.3389/fphys.2014.00480 . | Open in Read by QxMD
                                                                                          18. Vasopressin (Antidiuretic Hormone) . http://www.cvphysiology.com/Blood%20Pressure/BP016. Updated: August 12, 2016. Accessed: August 18, 2020.
                                                                                          19. Cuzzo B, Padala SA, Lappin SL . Vasopressin (Antidiuretic Hormone, ADH) . StatPearls [Internet]. 2020 .
                                                                                          20. Buford L, Nichols Jr . The role of antidiuretic hormone in corticotrophin release. . Yale J Biol Med. 1961 ; 33 (6) : p.415-434 .
                                                                                          21. Hobson RM, Maughan RJ . Hydration Status and the Diuretic Action of a Small Dose of Alcohol . Alcohol and Alcoholism. 2010 ; 45 (4) : p.366-373 . doi: 10.1093/alcalc/agq029 . | Open in Read by QxMD
                                                                                          22. Posovszky C, Wabitsch M . Regulation of Appetite, Satiation, and Body Weight by Enteroendocrine Cells. Part 1: Characteristics of Enteroendocrine Cells and Their Capability of Weight Regulation . Hormone Research in Paediatrics. 2015 ; 83 (1) : p.1-10 . doi: 10.1159/000368898 . | Open in Read by QxMD
                                                                                          23. Posovszky C, Wabitsch M . Regulation of Appetite, Satiation, and Body Weight by Enteroendocrine Cells. Part 2: Therapeutic Potential of Enteroendocrine Cells in the Treatment of Obesity . Hormone Research in Paediatrics. 2015 ; 83 (1) : p.11-18 . doi: 10.1159/000369555 . | Open in Read by QxMD
                                                                                          24. Hall J, Roberts R, Vora N . Energy Homoeostasis: The Roles of Adipose Tissue-Derived Hormones, Peptide YY and Ghrelin . Obesity Facts. 2009 ; 2 (2) : p.117-125 . doi: 10.1159/000208517 . | Open in Read by QxMD
                                                                                          25. DiPatrizio NV . Endocannabinoids in the Gut . Cannabis and Cannabinoid Research. 2016 ; 1 (1) : p.67-77 . doi: 10.1089/can.2016.0001 . | Open in Read by QxMD
                                                                                          26. Hillard CJ . Circulating Endocannabinoids: From Whence Do They Come and Where are They Going? . Neuropsychopharmacology. 2017 ; 43 : p.155-172 . doi: 10.1038/npp.2017.130 . | Open in Read by QxMD
                                                                                          27. Di Marzo V, Ligresti A, Cristino L . The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation . Int J Obes. 2009 ; 33 : p.S18-S24 . doi: 10.1038/ijo.2009.67 . | Open in Read by QxMD
                                                                                          28. Roth JD . Amylin and the regulation of appetite and adiposity . Current Opinion in Endocrinology & Diabetes and Obesity. 2013 ; 20 (1) : p.8-13 . doi: 10.1097/med.0b013e32835b896f . | Open in Read by QxMD
                                                                                          29. Katzung BG, Trevor AJ . Basic and Clinical Pharmacology 14E. McGraw-Hill Education / Medical ; 2017
                                                                                          30. Pertwee RG . Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities . Philosophical Transactions of the Royal Society B: Biological Sciences. 2012 ; 367 (1607) : p.3353-3363 . doi: 10.1098/rstb.2011.0381 . | Open in Read by QxMD
                                                                                          31. Yeh S, Schuster MW . Megestrol acetate in cachexia and anorexia . Int J Nanomedicine. 2006 ; 1 (4) : p.411-416 . doi: 10.2147/nano.2006.1.4.411 . | Open in Read by QxMD
                                                                                          32. Ruiz Garcia V, López-Briz E, Carbonell Sanchis R, Gonzalvez Perales JL, Bort-Martí S . Megestrol acetate for treatment of anorexia-cachexia syndrome . Cochrane Database of Systematic Reviews. 2013 ; 3 . doi: 10.1002/14651858.cd004310.pub3 . | Open in Read by QxMD
                                                                                          33. Mann M . Glucocorticoidlike Activity of Megestrol . Arch Intern Med. 1997 ; 157 (15) : p.1651-1656 . doi: 10.1001/archinte.1997.00440360053005 . | Open in Read by QxMD
                                                                                          34. Gillani SM, Singh BM . The use of GLP-1 agonist therapy, liraglutide, is associated with significant weight loss in morbidly obese people without diabetes . British Journal of Diabetes. 2015 ; 15 (2) : p.61-64 . doi: 10.15277/bjdvd.2015.011 . | Open in Read by QxMD
                                                                                          35. Abdel-Rahman MY . Androgen Excess Workup . In: Lucidi RS, Androgen Excess Workup. New York, NY : WebMD . http://emedicine.medscape.com/article/273153. Updated: August 1, 2016. Accessed: February 12, 2017.
                                                                                          36. Cordera F, Grant C, Van Heerden J, Thompson G, Young W . Androgen-secreting adrenal tumors . Surgery. 2003 ; 134 (6) : p.874-80 . doi: 10.1016/S0039 . | Open in Read by QxMD
                                                                                          37. Katzung B,Trevor A . Basic and Clinical Pharmacology. McGraw-Hill Education ; 2014
                                                                                          38. Rosol TJ, Yarrington JT, Latendresse J, Capen CC . Adrenal Gland: Structure, Function, and Mechanisms of Toxicity . Toxicol Pathol. 2001 ; 29 (1) : p.41-48 . doi: 10.1080/019262301301418847 . | Open in Read by QxMD